CONTROL OF AN SIVMAC239 TRANSMEMBRANE MUTANT IN PIGTAIL MACAQUES
尾猴中 SIVMAC239 跨膜突变体的控制
基本信息
- 批准号:8358143
- 负责人:
- 金额:$ 5.78万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2011
- 资助国家:美国
- 起止时间:2011-05-01 至 2012-04-30
- 项目状态:已结题
- 来源:
- 关键词:Acquired Immunodeficiency SyndromeAcuteBromodeoxyuridineCD4 Positive T LymphocytesCytoplasmic TailDiseaseExhibitsFundingGrantImmune responseInfectionLabelLamina PropriaMacaca mulattaMacaca nemestrinaMutationNational Center for Research ResourcesPrimatesPrincipal InvestigatorRNARecoveryResearchResearch InfrastructureResourcesSIVSignal TransductionSourceUnited States National Institutes of HealthViralViruscostdisorder controlinterestmacrophagemicrobialmonocytemutanttrafficking
项目摘要
This subproject is one of many research subprojects utilizing the resources
provided by a Center grant funded by NIH/NCRR. Primary support for the subproject
and the subproject's principal investigator may have been provided by other sources,
including other NIH sources. The Total Cost listed for the subproject likely
represents the estimated amount of Center infrastructure utilized by the subproject,
not direct funding provided by the NCRR grant to the subproject or subproject staff.
The pigtail macaque (PTM) is well recognized as being highly susceptible to SIV-induced disease, with SIVmac239 reproducibly and rapidly causing AIDS. We have shown that when SIVmac239 contains a mutation that ablates a GYxx¿ trafficking signal in the Env TM cytoplasmic tail, the resulting virus (GY) replicates to a high acute RNA peak (1.8-9.3x10^6 copies/ml) comparable to SIVmac239 in PTMs (p=0.90) and to GY in rhesus macaques (RhM) (p=0.93). In RhMs (n=4) GY acute infection is followed by a 2-3 log reduction in viral set point (VSP) with minimal acute loss of CD4 cells in the lamina propria, but with a gradual decline in CD4 cells over 1 year. However, in PTMs (n=4) with the onset of host immune responses GY is suppressed to extremely low to undetectable levels (15, 15, 15, and 210 copies/ml by 19 weeks post infection), much lower than SIVmac239 (p=0.003) and GY (p=0.007) in RhM. Strikingly, the sustained, severe depletion of lamina propria CD4 T-cells that occurs with SIVmac239 infection did not occur with GY in PTM; from preinfection levels (median 43.9 %; range 25.4 54.3%) only a modest reduction occurred during acute infection (median 18.4 %; range 8.4 20.7%) with evidence of recovery by 22 weeks (median 27 %; range 18.3 - 46%). Moreover, monocyte turnover, determined by BrdU labeling, which we have shown increases with pathogenic SIV infection, was only minimally and transiently increased in GY-infected PTMs compared to SIVmac239-infected RhMs (p=0.03), possibly reflecting a lower level of microbial translocation and/or macrophage infection. GY control is clearly not the result of poor replicative ability, given its high acute viral peak in both PTM and RhM. How the GY mutation alters the pathogenic potential of SIVmac239 and why PTMs, a more susceptible species for pathogenic SIVmac infection, exhibit better control of ¿GY than RhM will be of great interest in determining viral and host interactions that are relevant to virologic control and disease.
这个子项目是许多利用资源的研究子项目之一
由NIH/NCRR资助的中心拨款提供。子项目的主要支持
而子项目的主要调查员可能是由其他来源提供的,
包括其他NIH来源。 列出的子项目总成本可能
代表子项目使用的中心基础设施的估计数量,
而不是由NCRR赠款提供给子项目或子项目工作人员的直接资金。
猪尾猕猴(PTM)被公认为对SIV诱导的疾病高度易感,SIVmac 239可重复并迅速引起AIDS。我们已经证明,当SIVmac 239含有一个突变,消除了GYxx <$TM胞质尾区的运输信号时,产生的病毒(戈伊)复制到高急性RNA峰(1.8-9.3x10^6拷贝/ml),与PTM中的SIVmac 239相当(p=0.90), 恒河猴(RhM)中的戈伊(p=0.93)。在RhM中(n=4) 戈伊急性感染后,病毒设定点(VSP)降低2-3个对数,固有层中CD 4细胞的急性损失最小,但CD 4细胞在1年内逐渐下降。然而,在PTM(n=4)中,随着宿主免疫应答的发生, 戈伊被抑制至极低至检测不到的水平(感染后19周为15、15、15和210拷贝/ml),远低于SIVmac 239(p=0.003), RhM中的戈伊(p=0.007)。引人注目的是,SIVmac 239感染时固有层CD 4 T细胞的持续严重耗竭在SIVmac 239感染后没有发生。 PTM中的戈伊;与感染前水平相比(中位数43.9%;范围25.4 54.3%)仅在急性感染期间发生中度降低(中位数18.4%;范围8.4 20.7%),22周时有恢复证据(中位数27%;范围18.3 - 46%)。此外,通过BrdU标记确定的单核细胞更新,我们已经表明随着致病性SIV感染而增加,在感染SIV的小鼠中, 与SIVmac 239感染的RhM相比,GY感染的PTM(p=0.03),可能反映了较低水平的微生物易位和/或巨噬细胞感染。 戈伊对照显然不是复制能力差的结果,因为其在PTM和RhM中都具有高急性病毒峰。如何 戈伊突变改变了SIVmac 239的致病潜力,以及为什么PTM(一种对致病性SIVmac感染更敏感的物种)比RhM表现出更好的戈伊控制,这将在确定与病毒学控制和疾病相关的病毒和宿主相互作用方面引起极大的兴趣。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
James A Hoxie其他文献
James A Hoxie的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('James A Hoxie', 18)}}的其他基金
Targeted interventions to reduce or eliminate the SIV reservoir in a novel model of elite control
有针对性的干预措施,以减少或消除新型精英控制模型中的 SIV 储存库
- 批准号:
10013657 - 财政年份:2020
- 资助金额:
$ 5.78万 - 项目类别:
Targeted interventions to reduce or eliminate the SIV reservoir in a novel model of elite control
有针对性的干预措施,以减少或消除新型精英控制模型中的 SIV 储存库
- 批准号:
10371090 - 财政年份:2020
- 资助金额:
$ 5.78万 - 项目类别:
Role of SIV and HIV Env cytoplasmic tail in pathogenesis and protective immunity
SIV和HIV Env胞质尾在发病机制和保护性免疫中的作用
- 批准号:
10092084 - 财政年份:2018
- 资助金额:
$ 5.78万 - 项目类别:
Non-CD4 tropic SIV: Enhancing CD4 T-cell help in antiviral immune responses
非 CD4 tropic SIV:增强 CD4 T 细胞有助于抗病毒免疫反应
- 批准号:
8732145 - 财政年份:2014
- 资助金额:
$ 5.78万 - 项目类别:
PATHOGENESIS OF AN ATTENUATED SIVMAC239 IN RHESUS AND PIGTAIL MACAQUES
减毒 SIVMAC239 在恒河猴和尾猴中的发病机制
- 批准号:
8358095 - 财政年份:2011
- 资助金额:
$ 5.78万 - 项目类别:
Optimizing HIV Env immuogens for T and B cell vaccine responses
优化 HIV 包膜免疫原以实现 T 和 B 细胞疫苗反应
- 批准号:
8505364 - 财政年份:2010
- 资助金额:
$ 5.78万 - 项目类别:
Optimizing HIV Env immuogens for T and B cell vaccine responses
优化 HIV 包膜免疫原以实现 T 和 B 细胞疫苗反应
- 批准号:
8091276 - 财政年份:2010
- 资助金额:
$ 5.78万 - 项目类别:
Optimizing HIV Env immuogens for T and B cell vaccine responses
优化 HIV 包膜免疫原以实现 T 和 B 细胞疫苗反应
- 批准号:
7988637 - 财政年份:2010
- 资助金额:
$ 5.78万 - 项目类别:
Optimizing HIV Env immuogens for T and B cell vaccine responses
优化 HIV 包膜免疫原以实现 T 和 B 细胞疫苗反应
- 批准号:
8300199 - 财政年份:2010
- 资助金额:
$ 5.78万 - 项目类别:
PATHOGENIC DETERMINANTS OF THE SIV ENVELOPE TRANSMEMBRANE CYTOPLASMIC DOMAIN
SIV 包膜跨膜细胞质域的致病决定因素
- 批准号:
8173001 - 财政年份:2010
- 资助金额:
$ 5.78万 - 项目类别:
相似海外基金
Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
- 批准号:
MR/Y009568/1 - 财政年份:2024
- 资助金额:
$ 5.78万 - 项目类别:
Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
- 批准号:
10090332 - 财政年份:2024
- 资助金额:
$ 5.78万 - 项目类别:
Collaborative R&D
Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
- 批准号:
MR/X02329X/1 - 财政年份:2024
- 资助金额:
$ 5.78万 - 项目类别:
Fellowship
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
- 批准号:
MR/X021882/1 - 财政年份:2024
- 资助金额:
$ 5.78万 - 项目类别:
Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
- 批准号:
MR/X029557/1 - 财政年份:2024
- 资助金额:
$ 5.78万 - 项目类别:
Research Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
- 批准号:
EP/Y003527/1 - 财政年份:2024
- 资助金额:
$ 5.78万 - 项目类别:
Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
- 批准号:
EP/Y030338/1 - 财政年份:2024
- 资助金额:
$ 5.78万 - 项目类别:
Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
- 批准号:
2312694 - 财政年份:2024
- 资助金额:
$ 5.78万 - 项目类别:
Standard Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
- 批准号:
24K19395 - 财政年份:2024
- 资助金额:
$ 5.78万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Acute human gingivitis systems biology
人类急性牙龈炎系统生物学
- 批准号:
484000 - 财政年份:2023
- 资助金额:
$ 5.78万 - 项目类别:
Operating Grants